- Title
- Anxiety and depression among haematological cancer patients attending treatment centres: prevalence and predictors
- Creator
- Clinton-McHarg, Tara; Carey, Mariko; Sanson-Fisher, Rob; Tzelepis, Flora; Bryant, Jamie; Williamson, Anna
- Relation
- Journal of Affective Disorders Vol. 165, p. 176-181
- Publisher Link
- http://dx.doi.org/10.1016/j.jad.2014.04.072
- Publisher
- Elsevier
- Resource Type
- journal article
- Date
- 2014
- Description
- Background This study aimed to: (1) estimate the prevalence of anxiety and/or depression among haematological cancer patients attending treatment centres; and (2) explore the demographic, disease and treatment characteristics associated with anxiety and/or depression. Methods A cross-sectional study was conducted with outpatients from three haematology clinics in Australia. Patients with a confirmed diagnosis of haematological cancer were approached by a research assistant while waiting for their appointment and invited to participate in the survey. Participants completed the Hospital Anxiety and Depression Scale (HADS) and self-reported demographic, disease and treatment characteristics. Results Questionnaires from 304 participants were returned. Twenty-seven percent of patients reported anxiety and 17% reported depression. Specifically, 15% reported anxiety without depression, 5% reported depression without anxiety, and 12% reported comorbid anxiety and depression. Participants who had to relocate to receive treatment had almost three times the odds of reporting anxiety and/or depression compared to those who did not have to move. Former smokers also had significantly higher odds of reporting anxiety and/or depression. Limitations The HADS is likely to have produced some false positives and false negatives when compared with gold standard structured clinical interviews for assessing psychological morbidity. Conclusions Approximately 20% of haematological cancer patients attending outpatient clinics may experience clinically significant levels of anxiety and/or depression. Providing additional tailored support to patients who have had to relocate for treatment, and to former smokers, may help to reduce anxiety and depression among these subgroups.
- Subject
- anxiety; depression; cancer; haematology; treatment centre
- Identifier
- http://hdl.handle.net/1959.13/1300397
- Identifier
- uon:20063
- Identifier
- ISSN:0165-0327
- Language
- eng
- Full Text
- Reviewed
- Hits: 3235
- Visitors: 3957
- Downloads: 787
Thumbnail | File | Description | Size | Format | |||
---|---|---|---|---|---|---|---|
View Details Download | ATTACHMENT02 | Author final version | 325 KB | Adobe Acrobat PDF | View Details Download |